The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Patient satisfaction with cancer care delivery through telemedicine at a comprehensive cancer center across three years during and after the COVID-19 pandemic.
 
Sahil D Doshi
No Relationships to Disclose
 
Yasin Khadem Charvadeh
No Relationships to Disclose
 
Kenneth Seier
No Relationships to Disclose
 
Erin Mary Bange
Consulting or Advisory Role - Flatiron Health
 
Robert Michael Daly
Stock and Other Ownership Interests - CVS Health (I); Lilly (I); Roche/Genentech
Consulting or Advisory Role - Varian Medical Systems
 
Fernanda C. G. Polubriaginof
No Relationships to Disclose
 
Michael T. Buckley
Stock and Other Ownership Interests - Lilly; Novo Nordisk
 
Gilad Kuperman
No Relationships to Disclose
 
Peter D. Stetson
No Relationships to Disclose
 
Deb Schrag
Stock and Other Ownership Interests - Merck (I)
Consulting or Advisory Role - JAMA-Journal of the American Medical Association; Swiss Re Management Ltd.
Research Funding - AACR (Inst); GRAIL (Inst)
Patents, Royalties, Other Intellectual Property - PRISSMM model is trademarked and curation tools are available to academic medical centers and government under creative commons license.
 
Michael J. Morris
Stock and Other Ownership Interests - Doximity
Consulting or Advisory Role - Ambrx; Arvinas; AstraZeneca; Blue Earth Diagnostics; Bristol-Myers Squibb/Celgene; Clarity Pharmaceuticals; Convergent Therapeutics; Core Medica; Curium Pharma; Daiichi; Exelixis; Flare Therapeutics; Fusion Pharmaceuticals; ITM Isotope Technologies Munich; Lantheus Medical Imaging; Mashup Media; Pfizer; POINT Biopharma; Progenics; Telix Pharmaceuticals; Transtherabio; Z-Alpha
Research Funding - Astellas Pharma (Inst); Celgene (Inst); Corcept Therapeutics (Inst); Janssen (Inst); Novartis (Inst)
Travel, Accommodations, Expenses - Amgen; APCCC; AstraZeneca; Memorial Sloan-Kettering Cancer Center
Other Relationship - Novartis
(OPTIONAL) Uncompensated Relationships - Amgen; Amgen; Bayer; Janssen Oncology; Novartis
 
Katherine Panageas
Stock and Other Ownership Interests - 23andMe; Adicet Bio; Chinook Therapeutics; Codexis; T2 Biosystems; Vincerx Pharma
Research Funding - AACR (Inst)
Travel, Accommodations, Expenses - The Robert A. Winn Diversity in Clinical Trials Award Program (Winn Awards) in collaboration with the American Association for Cancer Research (AACR), Bristol Myers Squibb Foundation